Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on September 2, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Byrna Appoints Matt McBrady to Board of Directors
Supernus Pharmaceuticals to Participate in September Investor Conferences
Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
Methode Electronics, Inc. Reports Fiscal 2027 First Quarter Financial Results
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
Shufti Ranks #1 in G2 Fall 2026 Grid® Report for Identity Verification and AML, Earns 40+ Badges Across 12 Categories
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
nCino to Participate in Upcoming Investor Event 
Surrozen to Present at Upcoming Healthcare Investor Conferences
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Gold.com Reports Fiscal Fourth Quarter and Full Year 2026 Results
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
Netskope Announces Strong Second Quarter Fiscal 2027 Financial Results
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
SPS Commerce to Present at Citi's 2026 Global TMT Conference

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.